| Product Code: ETC7765113 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Neurological Biomarkers Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Neurological Biomarkers Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Neurological Biomarkers Market - Industry Life Cycle |
3.4 Jordan Neurological Biomarkers Market - Porter's Five Forces |
3.5 Jordan Neurological Biomarkers Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Jordan Neurological Biomarkers Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Jordan Neurological Biomarkers Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Jordan Neurological Biomarkers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Jordan |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of neurological conditions |
4.2.3 Technological advancements in biomarker research and diagnostic tools |
4.3 Market Restraints |
4.3.1 Limited availability of skilled healthcare professionals specializing in neurological biomarkers |
4.3.2 High cost associated with biomarker testing and diagnosis in Jordan |
5 Jordan Neurological Biomarkers Market Trends |
6 Jordan Neurological Biomarkers Market, By Types |
6.1 Jordan Neurological Biomarkers Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Jordan Neurological Biomarkers Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Jordan Neurological Biomarkers Market Revenues & Volume, By Genomic Biomarkers, 2021- 2031F |
6.1.4 Jordan Neurological Biomarkers Market Revenues & Volume, By Proteomic Biomarkers, 2021- 2031F |
6.1.5 Jordan Neurological Biomarkers Market Revenues & Volume, By Metabolomic Biomarkers, 2021- 2031F |
6.1.6 Jordan Neurological Biomarkers Market Revenues & Volume, By Imaging Biomarkers, 2021- 2031F |
6.1.7 Jordan Neurological Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Jordan Neurological Biomarkers Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Jordan Neurological Biomarkers Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F |
6.2.3 Jordan Neurological Biomarkers Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F |
6.2.4 Jordan Neurological Biomarkers Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.2.5 Jordan Neurological Biomarkers Market Revenues & Volume, By Autism Spectrum Disorders, 2021- 2031F |
6.2.6 Jordan Neurological Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Jordan Neurological Biomarkers Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 Jordan Neurological Biomarkers Market Revenues & Volume, By Hospital Laboratories, 2021- 2031F |
6.3.3 Jordan Neurological Biomarkers Market Revenues & Volume, By Clinical Diagnostic Centers, 2021- 2031F |
6.3.4 Jordan Neurological Biomarkers Market Revenues & Volume, By Research Organizations, 2021- 2031F |
6.3.5 Jordan Neurological Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
7 Jordan Neurological Biomarkers Market Import-Export Trade Statistics |
7.1 Jordan Neurological Biomarkers Market Export to Major Countries |
7.2 Jordan Neurological Biomarkers Market Imports from Major Countries |
8 Jordan Neurological Biomarkers Market Key Performance Indicators |
8.1 Number of research studies conducted on neurological biomarkers in Jordan |
8.2 Adoption rate of neurological biomarker testing by healthcare institutions in Jordan |
8.3 Investment in research and development of new biomarkers for neurological disorders in Jordan |
9 Jordan Neurological Biomarkers Market - Opportunity Assessment |
9.1 Jordan Neurological Biomarkers Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Jordan Neurological Biomarkers Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Jordan Neurological Biomarkers Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Jordan Neurological Biomarkers Market - Competitive Landscape |
10.1 Jordan Neurological Biomarkers Market Revenue Share, By Companies, 2024 |
10.2 Jordan Neurological Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here